We are live on ! Find out more
FIA

FNY Investment Advisers Portfolio holdings

AUM $278M
1-Year Est. Return 98.99%
This Fund
S&P 500
This Quarter Est. Return
+23.2%
1 Year Est. Return
+98.99%
3 Year Est. Return
+307.32%
5 Year Est. Return
+396.61%
10 Year Est. Return
–
AUM
$311M
AUM Growth
+$75M
Cap. Flow
+$46.3M
Cap. Flow %
14.89%
Top 10 Hldgs %
18.62%
Holding
1,633
New
628
Increased
240
Reduced
242
Closed
312

Top Buys

Rank Stock Value
1
VRNA
Verona Pharma
VRNA
+$15.5M
2
SBSW icon
Sibanye-Stillwater
SBSW
+$3.75M
3
UNH icon
UnitedHealth
UNH
+$3.2M
4
FCRS.U
FutureCrest Acquisition Corp Units
FCRS.U
+$2.72M
5
TLT icon
iShares 20+ Year Treasury Bond ETF
TLT
+$2.71M

Top Sells

Rank Stock Value
1
BPMC
Blueprint Medicines
BPMC
+$5.26M
2
VOD icon
Vodafone
VOD
+$5.12M
3
ERIC icon
Ericsson
ERIC
+$4.88M
4
JNPR
Juniper Networks
JNPR
+$4.21M
5
CCIR
Cohen Circle Acquisition Corp. I Class A Ordinary Shares
CCIR
+$3.45M

Sector Composition

Rank Sector Weight
1 Technology 25.26%
2 Healthcare 12.39%
3 Financials 11.37%
4 Consumer Discretionary 7.84%
5 Industrials 6.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MYGN icon
651
Myriad Genetics
MYGN
$303M
$21K 0.01%
+2,930
New +$17.4K
NAD icon
652
Nuveen Quality Municipal Income Fund
NAD
$2.77B
$21K 0.01%
1,800
– –
PMVP icon
653
PMV Pharmaceuticals
PMVP
$65.1M
$21K 0.01%
+15,000
New +$20.8K
VTGN icon
654
VistaGen Therapeutics
VTGN
$11.8M
$21K 0.01%
+6,000
New +$17.9K
WLK icon
655
Westlake Corp
WLK
$10.2B
$21K 0.01%
+273
New +$22.8K
SMCY
656
YieldMax SMCI Option Income Strategy ETF
SMCY
$133M
$21K 0.01%
+1,400
New +$25K
ENB icon
657
Enbridge
ENB
$112B
$20K 0.01%
400
-400
-50% -$18.8K
FRO icon
658
Frontline
FRO
$9.02B
$20K 0.01%
+900
New +$18.2K
NZF icon
659
Nuveen Municipal Credit Income Fund
NZF
$2.45B
$20K 0.01%
1,600
– –
RAIL icon
660
FreightCar America
RAIL
$243M
$20K 0.01%
+2,048
New +$19.6K
RNXT icon
661
RenovoRx
RNXT
$56.8M
$20K 0.01%
+16,000
New +$19K
RXRX icon
662
Recursion Pharmaceuticals
RXRX
$1.78B
$20K 0.01%
4,117
+440
+12% +$2.31K
STLN
663
Starling Oncology, Inc. Common Stock
STLN
$638M
$20K 0.01%
6,000
+2,000
+50% +$6.85K
TTEC icon
664
TTEC Holdings
TTEC
$77.4M
$20K 0.01%
6,000
– –
AMD icon
665
CALL
Advanced Micro Devices
AMD
$789B
$19K 0.01%
+120
New +$19.4K
CASY icon
666
Casey's General Stores
CASY
$31.6B
$19K 0.01%
+34
New +$17.8K
CRDO icon
667
Credo Technology Group
CRDO
$49.6B
$19K 0.01%
+136
New +$16.6K
JRS icon
668
Nuveen Real Estate Income Fund
JRS
$248M
$19K 0.01%
2,400
– –
MFA
669
MFA Financial
MFA
$931M
$19K 0.01%
+2,100
New +$20.3K
NJR icon
670
New Jersey Resources
NJR
$5.64B
$19K 0.01%
400
– –
PB icon
671
Prosperity Bancshares
PB
$8.97B
$19K 0.01%
300
– –
PROP icon
672
Prairie Operating Co
PROP
$82.1M
$19K 0.01%
9,800
-5,576
-36% -$15.9K
RYAN icon
673
Ryan Specialty Holdings
RYAN
$11B
$19K 0.01%
+342
New +$20.3K
SNV
674
DELISTED
Synovus
SNV
$19K 0.01%
400
– –
UHAL icon
675
U-Haul Holding Co
UHAL
$14.4B
$19K 0.01%
+342
New +$20.2K
25 26
27
28 29

Similar funds

ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
CC
Checkpoint Capital San Francisco, California $279M AUM 45.74% 1-Year Est. Return
SL
SOF Ltd George Town, Cayman Islands $279M AUM 6.12% 1-Year Est. Return
BCH
Berkshire Capital Holdings San Jose, California $277M AUM 190.28% 1-Year Est. Return
NCM
NCM Capital Management Ramsey, New Jersey $279M AUM 26.47% 1-Year Est. Return
RFA
Resurgent Financial Advisors Atlanta, Georgia $277M AUM 21.5% 1-Year Est. Return
HCM
Hall Capital Management Barrington, Rhode Island $280M AUM 14.82% 1-Year Est. Return
EFP
Envision Financial Planning Memphis, Tennessee $276M AUM 10.87% 1-Year Est. Return

FNY Investment Advisers's Q3 2025 Portfolio in Review

As of Q3 2025, FNY Investment Advisers held 1,633 positions worth $311M, up 32% from $236M the previous quarter. Its ten largest holdings account for 19% of the portfolio.

FNY Investment Advisers deployed $46.3M of net new capital in Q3 2025, opening 628 new positions and adding to 240 existing holdings. Its largest new stake was Verona Pharma: 148,120 shares worth $15.8M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Ramaco Resources Class A, an estimated $3.39M trimmed.

  • FNY Investment Advisers's largest Q3 2025 buy was Verona Pharma: 148,120 shares worth $15.8M.
  • FNY Investment Advisers added most to UnitedHealth in Q3 2025, an estimated $3.2M increase.
  • FNY Investment Advisers's biggest Q3 2025 reduction was Ramaco Resources Class A, cutting an estimated $3.39M.
  • FNY Investment Advisers fully exited Blueprint Medicines in Q3 2025, selling an estimated $5.26M.
  • FNY Investment Advisers's ten largest holdings make up 19% of its $311M portfolio in Q3 2025.
  • FNY Investment Advisers opened 628 new positions and closed 312 in Q3 2025.
  • FNY Investment Advisers's portfolio value rose 32% quarter-over-quarter to $311M.

Based on FNY Investment Advisers's 13F filing for Q3 2025, filed 15 Dec 2025.